source
- Galderma gets CRL for anti-wrinkle drug; Kimball buys CDMO for $103MPlus more from Lonza, Icosagen and others. 🟥 Galderma’s CRL: Galderma has received a complete response letter from the FDA for its relabotulinumtoxinA, a drug being reviewed as a neuromodulator to…Endpoints · 27d ago↗ source
- How Butterfly, once known for its handheld ultrasound device, is growing its chip-making businessNvidia got its start as a gaming chip maker before meteoric success selling its chips to nearly every industry. One health tech company is hoping to go down a similar route. Last month, ultrasound…Endpoints · 27d ago↗ source
- Roche’s KRAS G12C inhibitor beats rivals in head-to-head Phase 3 studyRoche’s lung cancer drug candidate divarasib has beaten marketed drugs from Amgen and Bristol Myers Squibb in a head-to-head trial. Full data haven't yet emerged, but if the drug's survival benefit…